Botulism outbreaks highlight the need for detection of food contamination at point of use. Printed on the inside of a jar lid, for example, a biosensing ink can tell the consumer if the product they are about to consume is sterile or contaminated by a simple change in color.

BUFFALO, NY — August 14, 2025 — A new research paper was published in Volume 17, Issue 7, of Aging (Aging-US) on July 3, 2025, titled “Frailty associates with respiratory exacerbations and mortality in the COPDGene cohort.”

Cambridge, MA – Aug 14, 2025 – Insilico Medicine(“Insilico”), a clinical-stage biotechnology company driven by generative artificial intelligence (AI), today announced that ISM8969, an orally available NLRP3 inhibitor targeting inflammation and neurodegenerative disorders, has completed IND-enabling studies with favorable results. Insilico plans to submit IND application in Q4 this year, aiming to progress the candidate compound into clinical trials as a potential transformative therapy for Parkinson’s disease (PD).

The number of people suffering from kidney disease is rising worldwide. According to estimates by the World Health Organization (WHO), kidney disease will be one of the five leading causes of death by 2050. Kidney disease often goes undetected for a long time, meaning that damage is already at a critical stage and usually irreversible by the time it is noticed. As its basic mechanisms are not yet fully understood, more research is essential to improve our understanding of the disease and enable its successful prevention and early detection. A research team with scientists from Dresden and Heidelberg, alongside their international partners, has now identified new mechanisms that explain why kidney damage differs significantly between women and men. These findings are attributable to the effect of the hormone estrogen. The study, entitled “Multiple oestradiol functions inhibit ferroptosis and acute kidney injury,” has now been published in the renowned journal Nature.